Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TSPO | P30536 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4172097 | 0.90 | ALDH1A1 (0.55) | RENALDH1A1OPRM1NPSR1LMNA | |
| SCHEMBL4165741 | 0.88 | LTB4R2 (0.53) | RENALDH1A1LMNACNR2LTB4R2 | |
| SCHEMBL14224515 | 0.87 | HDAC1 (0.58) | RENALDH1A1OPRM1NPSR1LMNA | |
| SCHEMBL4155334 | 0.86 | HDAC6 (0.59) | RENALDH1A1LMNACNR2LTB4R2 | |
| SCHEMBL28319972 | 0.86 | ALDH1A1 (0.56) | RENALDH1A1OPRM1NPSR1LMNA | |
| SCHEMBL4170612 | 0.85 | CNR2 (0.56) | RENALDH1A1LMNACNR2LTB4R2 | |
| SCHEMBL6433208 | 0.84 | ALDH1A1 (0.64) | ALDH1A1OPRM1NPSR1LMNAMEN1 | |
| SCHEMBL4155178 | 0.84 | CNR2 (0.58) | RENALDH1A1LMNACNR2LTB4R2 | |
| SCHEMBL4163435 | 0.84 | CNR2 (0.58) | RENALDH1A1LMNACNR2LTB4R2 | |
| SCHEMBL4161736 | 0.84 | CNR2 (0.58) | RENALDH1A1LMNACNR2LTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090088438-A1 | NEW TYROSINE DERIVATIVES AS PPARy MODULATORS | LABORATORIOS SALVAT, S.A. (ES) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088438-A1 | NEW TYROSINE DERIVATIVES AS PPARy MODULATORS | PPARG, PPARD, TYRO3 | REN 989/4885ALDH1A1 2505/4885OPRM1 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.